The DOI matches its Crossref record.
Regulation of Porphyrin Synthesis and Photodynamic Therapy in Heavy Metal Intoxication
Abstract
Protoporphyrin IX (PpIX) synthesis by malignant cells is successfully exploited for photodynamic therapy (PDT) following administration of 5-aminolevulinic acid (ALA) and light irradiation. The influence of two environmental heavy metal poisons, lead and gallium, on PpIX-synthesis and ALA-PDT was studied in two neu-ronal cell lines, SH-SY5Y neuroblastoma and PC12 pheochromocytoma. The heavy metal intoxication affected two of the heme-synthesis enzymes, ALA-dehydratase (ALAD) and porphobilinogen deaminase (PBGD). The present results show that lead poisoning significantly decreased the PBGD cellular level and inhibited its enzymatic activity, whereas the effects of gallium were less prominent. Although, the protein levels were reduced, the mRNA levels of PBGD remained unchanged during metal intoxication. These findings show additional inhibitory activity of lead on top of its classical effect on ALAD. Proteasome activity was enhanced during lead treatment, as measured by the AMC fluorigenic proteasome assay. The reduction in PBGD levels was not a consequence of PBGD mRNA reduced synthesis, which remained unchanged as shown by RT-PCR analysis. As a result of the lead poisoning, marked alterations in the cell cycle were observed, including a decreased G1 phase and an increased number of S phase cells. The efficacy of ALA-PDT was reduced in correlation with decreased activities of the enzymes during lead intoxication. We may conclude that lead poisoning adversely affects the outcome of ALA photodynamic therapy of cancer.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Inhibition of PBGD with Pb2+ has similar effects to ALAD silencing.
“Similar effects have been presented for inhibition of PBGD with Pb2+ [46].”
From Aminolevulinic Acid (ALA) as a Prodrug in Photodynamic Therapy of Cancer (2011) · cites this paper as [46]
Citations
Cites
Still being checked.
Cited by
Sorted by citations
Aminolevulinic Acid (ALA) as a Prodrug in Photodynamic Therapy of Cancer
Wachowska, M., Muchowicz, A., Firczuk, M., Gabrysiak, M., Winiarska, M., Wańczyk, M., Bojarczuk, K., & Golab, J. (2011) · Molecules · doi:10.3390/molecules16054140 · Cited by 265
Ohgari, Y., Miyata, Y., Miyagi, T., Gotoh, S., Ohta, T., Kataoka, T., Furuyama, K., & Taketani, S. (2011) · Photochemistry and Photobiology · doi:10.1111/j.1751-1097.2011.00950.x · Cited by 34
The centrality of PBGD expression levels on ALA-PDT efficacy
Schauder, A., Feuerstein, T., & Malik, Z. (2011) · Photochemical & Photobiological Sciences · doi:10.1039/c1pp05085k · Cited by 22
Self-citationSilencing of ALA dehydratase affects ALA-photodynamic therapy efficacy in K562 erythroleukemic cells
Feuerstein, T., Schauder, A., & Malik, Z. (2009) · Photochemical & Photobiological Sciences · doi:10.1039/b9pp00007k · Cited by 19
Self-citationGrünberg-Etkovitz, N., Greenbaum, L., Grinblat, B., & Malik, Z. (2006) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2006.07.005 · Cited by 12
Self-citationРабинович, О. Ф., Гусева, А. В., & Абрамова, Е. С. (2015) · Stomatology · doi:10.17116/stomat201594240-46 · Cited by 4
Radka, T. (2013) · The University of Bath Online Publications Store (The University of Bath)
Metadata
- Authors
- Grinblat, B., Pour, N., & Malik, Z.
- Affiliations
- Bar-Ilan University (IL)
- ORCID
- Malik, Zvi
- Venue
- Journal of Environmental Pathology, Toxicology and Oncology
- Publisher
- Begell House
- Published
- 2006
- Volume
- 25
- Issue
- 1-2
- Pages
- 145-158
- ISSN
- 0731-8898 (ISSN-L)
- OpenAlex
- W1977180105
- Cited by
- 7
- References
- 0
- Citations by year
- 2015: 1 · 2013: 1
- FWCI
- 0.27
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Environmental Pathology Toxicology and Oncology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Porphyrin Metabolism and Disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Photodynamic Therapy Research Studies
- Physical Sciences › Environmental Science › Health, Toxicology and Mutagenesis › Heavy Metal Exposure and Toxicity
- Keywords
- porphyrin synthesis, photodynamic therapy, 5-aminolevulinic acid, lead poisoning, gallium, protoporphyrin IX, porphobilinogen deaminase, ALAD, heme biosynthesis, proteasome activity, cell cycle, PC12 cells, neuroblastoma, cancer therapy
- MeSH terms
- Aminolevulinic Acid, Porphobilinogen Synthase, Animals, Cell Cycle, Enzyme Inhibitors, Gallium, Humans, Lead, Neurons, Photochemotherapy, Hydroxymethylbilane Synthase, Protoporphyrins, RNA, Messenger, PC12 Cells, Photosensitizing Agents, Proteasome Endopeptidase Complex, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review